Our services
Genetic cancer evaluation
iCellate’s genetic cancer evaluation, using circulating tumor cells (CTC) or circulating tumor DNA (ctDNA), provides detailed genetic tumor information which may reveal new targeted treatment options.
Genetic cancer evaluation
A genetic cancer evaluation is for those who have already been diagnosed with cancer. The public healthcare system follow established guidelines, while private alternatives may offer cutting edge technology early. iCellate has developed new methods, which likely will become standard of care in a few years.
A blood sample can show presence of tumor fragments (called ctDNA). The DNA fragments can be analyzed (sequenced). The resulting list of genetic defects, presented in a clinical report may suggest individualized treatment options.
It is important that you as a patient and your doctor agree on which tests that will provide the desired information.
iCellate's expert is always available if you have a specific question about the test or the report.
Inherited cancer risk
You, who have relatives affected by cancer, should consider assessing your own risk of developing cancer. Scientific studies show that 5-10% of all cancer diagnoses have a hereditary component. Less well known is that in many cases even inherited cancer can be preventable.
One of the most well-known hereditary cancer genes are BRCA1 and BRCA2. Anyone who has an inherited mutation in any of these genes has a significantly higher risk of developing breast or ovarian cancer (for women) or prostate cancer (for men).
With so-called germlineDNA (gDNA), your inherited tendencies to develop cancer are analyzed by DNA sequencing. Since your genome is not changing, the test only needs to be done once in a life-time.
DOWNLOAD DETAILED DESCRIPTION
DOWNLOAD ORDER FORM
Personal cancer screening
There is not yet a universal cancer-test in the public healthcare system for finding cancer early, i.e. screening. The tests that are available, such as mammography (for breast cancer) and PSA (for prostate cancer) are only focused on one type of cancer and the benefit is therefore limited.
iCellate has demonstrated through two major scientific studies (see here) that our technology serves well as a screening tool
If you choose to take iCellate’s Personal cancer screening test, you should familiarize yourself with the consequences. What does a positive test result (that there are traces of cancer in the blood) mean for you? Read more under the FAQs.
DOWNLOAD DETAILED DESCRIPTION
DOWNLOAD ORDER FORM
